Cutler Group LP Jazz Pharmaceuticals PLC Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$141.59 - $168.66 $5,238 - $6,240	-37 Reduced 27.01%	100 $15,000
Q1 2022 Apr 14, 2022	SELL	$129.64 - $160.7 $47,059 - $58,334	-363 Reduced 72.6%	137 $21,000
Q4 2021 Jan 18, 2022	SELL	$119.87 - $145.67 $3,955 - $4,807	-33 Reduced 6.19%	500 $63,000
Q3 2021 Oct 26, 2021	BUY	$128.64 - $184.79 $1,543 - $2,217	12 Added 2.3%	533 $69,000
Q2 2021 Jul 19, 2021	BUY	$160.2 - $186.42 $19,384 - $22,556	121 Added 30.25%	521 $92,000
Q1 2021 Apr 26, 2021	BUY	$150.19 - $173.5 $60,076 - $69,400	400 New	400 $65,000
Q4 2020 Jan 21, 2021	SELL	$140.71 - $165.05 $478,414 - $561,170	-3,400 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$105.46 - $144.13 $292,124 - $399,240	2,770 Added 439.68%	3,400 $484,000
Q2 2020 Jul 22, 2020	BUY	$95.68 - $121.88 $60,278 - $76,784	630 New	630 $69,000
Q1 2018 May 11, 2018	SELL	$135.59 - $157.16 $13,559 - $15,716	-100 Closed	0 $0
Q4 2017 Jan 17, 2018	BUY	$131.06 - $150.39 $13,106 - $15,038	100	100 $13,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.